Keyphrases
Immunogenicity
100%
Intradermal Delivery
100%
Phosphoinositide Lipid
100%
Nicotine Vaccine
100%
Vaccine Adjuvant
66%
Nicotine
33%
Vaccine Immunogenicity
33%
Intradermal Immunization
33%
CpG Adjuvant
33%
Reactogenicity
16%
Safer Alternatives
16%
Extended Period
16%
Skin Reactions
16%
Skin Irritation
16%
Tobacco Addiction
16%
Vaccination Dose
16%
Intramuscular Immunization
16%
Local Reactogenicity
16%
Noninflammatory
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Nicotine Vaccine
100%
Phosphoryl Lipid A
100%
Adjuvant
100%
Vaccine Adjuvant
80%
Tobacco Dependence
20%
Skin Manifestation
20%
Skin Irritation
20%
Immunotherapy
20%
Immunology and Microbiology
Immunogenicity
100%
Adjuvant
100%
Phosphoryl Lipid A
100%
Nicotine Vaccine
100%
Vaccine Adjuvant
80%
Vaccine Immunogenicity
40%
Immunotherapy
20%